The maps show where every company sits. This page ranks them. Up to three companies per chain — 73 companies shown, drawn from the 294 that cleared the gates across 25 chains. They are ranked on sustained growth, return on capital, operating margin against the chain’s own median, with debt as a hard gate, and now with two further tests that a company’s growth has to be steady and has to still be happening. The leader in each chain carries a written note checked against its latest results. Where it disagrees with best positioned, which is an argued page rather than a screen, each chain says so.
Read this first — not investment advice
This page is not investment advice, a recommendation, or an offer to buy or sell any security. It is the output of a mechanical screen run over a public dataset, plus a written note on the leading company in each chain. Nobody here is a registered investment adviser or research analyst, and nothing on this page is tailored to any reader’s circumstances, objectives or risk tolerance.
“Best performing” on this page means one specific thing: ranked highest by this screen, on past reported figures. It does not mean the shares are cheap, that the business will keep performing, or that it is a good thing to own. Past growth and past returns on capital do not predict future returns, and the price you would pay is not part of the ranking at all.
Every figure is trailing and dated. The ratios come from a single export taken on 8 Sep 2026; company results and policy figures in the written notes were checked in August 2026 and will go stale. Errors are possible and some are certain. Verify anything here against the company’s own filings before you act on it, and take advice from a SEBI-registered adviser if you need it.
The leader in every chain
One row per chain, the top-ranked company only. “Sustained growth” is the lower of the 3-year and 5-year sales CAGR; “return” is ROCE, or ROE for lenders and fee businesses. The last column flags where the company’s most recent quarter points the other way from the trailing screen — read those entries in full before anything else.
Sustained growth is min(3-year, 5-year sales CAGR) — the same rule the leader strip on every map uses, so this page cannot contradict the maps. A company has to have compounded over both windows.
No boom–bust. The two windows have to tell the same story: the 3-year and 5-year sales CAGRs may not differ by more than 2.2×, and profit by more than 3.0×. This is what removes a company whose five-year rate is a recent spike off a depressed base.
Still growing. Trailing-twelve-month sales and profit growth must both clear 8%. A five-year record that stopped last year is a history lesson, not a position.
Returns are ROCE for operating companies and ROE for lenders, insurers and fee businesses, where ROCE carries no information.
Margin is operating margin scored against the median of that chain, not a fixed bar — a 4% margin in contract assembly and a 56% margin in mining are both good, in context.
Debt is a hard gate at 1.5× equity, not a penalty. A company that clears on returns only because it is levered is not well positioned, it is geared. Financials are exempt — leverage there is the business.
Floors: ₹2,000 Cr market cap, ₹500 Cr revenue, and a 3-year sales CAGR must exist.
The small-base check. The oldest objection to any CAGR screen is a tiny denominator. Implied revenue five years ago is computed for every company on this page from its own reported 5-year CAGR; the smallest across all 73 picks is ₹140 Cr. None of these rates is measuring a company that barely existed.
The composite is the mean of the within-chain percentile ranks of growth, return and margin-z, ties broken by return. A chain shows fewer than three names — or none — when fewer clear the gates. It is never padded.
Price is not in the screen. Nothing here considers what a share costs. A company can lead its chain on this page and still be a poor thing to buy at the current price. That is a deliberate limit, not an oversight.
What this is not. A screen is not a view. It says nothing about whether a barrier is durable, whether growth was bought, or what the price already reflects. Read it against the chain the company sits in.
Chains where nothing cleared: The Water Value Chain. This page is never padded. Where no company in a chain gets through the gates, the chain is left out and named here instead — that is a finding about the chain, not an oversight. The usual cause is the boom–bust test: a chain whose best names are recovering from a depressed base rather than compounding.
Chain by chain
Each chain shows its leader with a written note, then the second and third names as screen output.
Q1 FY27 (reported July 2026): revenue ₹819.7 Cr, +172% YoY; PAT ₹85.3 Cr, +180%; operating EBITDA margin 14.7%.
The case
Confirmed order book ₹2,506.9 Cr at 30 June 2026, plus ₹848 Cr at L1 and a stated pipeline of ₹10,410 Cr — several times trailing revenue. It sits at the ODM and design stage of the electronics chain rather than in contract assembly, which is why it earns a 14.7% EBITDA margin where assemblers earn 3–4%. The demand anchor is dated and public: the IndiaAI Mission carries a sanctioned outlay of ₹10,372 Cr and had more than 38,000 GPUs onboarded to its common compute facility by 25 March 2026.
The bear case
Customer concentration moved the wrong way as revenue tripled. The top 10 customers were 87.71% of Q1 FY27 revenue, up from 76.42% in FY26. A revenue line growing this fast while concentrating is one contract renewal away from a step down, and the order book gives no protection against that.
What would break it: Top-10 concentration staying above 85% while order-book growth stalls.
Q1 FY27 (reported late July 2026): total income ₹8,933 Cr, +21.9% YoY; PAT ₹1,653.6 Cr, +46%; NIM 8.2%.
The case
AUM ₹2,54,392 Cr at 30 June 2026, up 23% year on year, on disbursements of ₹29,612 Cr, up 22%, with capital adequacy at 19.81%. ICRA projects NBFC-retail AUM growth of 16–18% in FY2027 — Chola is compounding several points above its own market, and has done so across more than one credit cycle.
The bear case
Asset quality moved against it over the year. Gross Stage 3 assets rose to 3.29% at 30 June 2026 from 2.62% a year earlier, 67 basis points, with gross NPA at 4.50% and net NPA 2.95% under revised RBI classification norms. At roughly 6.9× leverage the equity absorbs credit costs first, and the insurance subsidiary dragged on the consolidated Q1 print.
What would break it: Stage 3 pushing past ~4% while disbursement growth holds — that combination means growth is being bought with credit quality.
Q1 FY27 (reported August 2026): consolidated revenue ₹4,552 Cr, +21.3% YoY; PAT ₹884 Cr, +30.3%; operating margin 26.2%, up 116bps; underlying volume growth 11%.
The case
The branded half is the faster half: Consumer & Bazaar revenue ₹3,681 Cr, up 22.4%, against B2B at ₹918 Cr, up 13.8%. India's construction chemicals market is forecast to grow from US$2.8bn in 2026 to US$4.8bn by 2034, a 6.49% CAGR — Pidilite is growing revenue at roughly three times that rate, which is share gain rather than market growth.
The bear case
Its key input ran away from it. Vinyl acetate monomer went from $924 a tonne in Q1 FY26 to $1,370 in Q1 FY27 on the West Asia conflict, cutting gross margin 66bps year on year and 313bps sequentially. Management's own guided operating margin band is 20–24%, below the 26.2% just printed — the company is telling you this margin is not the run rate.
What would break it: Operating margin reverting into the guided 20–24% band while volume growth stays near 11% — that is the input cost winning.
Q1 FY27 (reported 13 July 2026): revenue ₹532.3 Cr, +34.6% YoY; standalone PAT ₹47.1 Cr, +54.0%; EBITDA ₹89 Cr at a 16.7% margin against 16.6%.
The case
Installed capacity of 6.15 lakh MTPA after expansions completed by 31 March 2026 that added 165,000 MTPA of NPK/DAP and 99,000 MTPA of sulphuric acid at Meghnagar, plus a ten-year, 70,000 MTPA green ammonia purchase agreement with SECI supplying from FY29. The Union Cabinet approved ₹41,534 Cr of Nutrient Based Subsidy for P&K fertilisers for Kharif 2026 (1 April to 30 September 2026), up from ₹37,216 Cr for Kharif 2025.
The bear case
The smallest leader on this page at a ₹6,020 Cr market cap, and the balance sheet moved sharply to fund the expansion: borrowings rose to ₹733 Cr in FY26 from ₹376 Cr in FY25, a debt-to-equity of about 1.18×, with finance costs climbing to ₹20.8 Cr in Q1 FY27 from ₹13.5 Cr in Q4 FY26 post-commissioning. Earnings depend on the NBS framework — an annual Cabinet decision — and on sulphur prices management has flagged as volatile on shipping disruption.
What would break it: NBS rates cut in a future season while leverage is still above 1×.
Q1 FY27 (reported 22 July 2026): revenue from operations ₹6,378.2 Cr, +25.2% YoY; standalone PAT ₹975.1 Cr, +47.9% (consolidated ₹958.7 Cr, +48.3%); EBITDA ₹1,538.1 Cr at a 24.1% margin.
The case
All four product groups grew double digits in the June 2026 quarter, exports grew 35.6% year on year, and the company reported a 20th consecutive quarter of double-digit beverages growth. Capex guidance is above ₹2,000 Cr a year, including a tenth Indian factory at Khordha, Odisha — a ₹900 Cr first phase whose foundation was laid on 4 April 2025. It leads both the Dairy and Sugar chains on this screen, at an 84.1% return on capital.
The bear case
The 48% profit jump is measured against a depressed base: Q1 FY26 profit had itself fallen 12% to ₹659 Cr. Management flagged cocoa and sugar as inflationary on erratic rainfall and lower crop estimates, plus demand-driven inflation in dairy proteins. UNVERIFIABLE: no credible dated multi-year forecast for India's packaged-foods market could be sourced for this entry, so it carries no market-size claim — the convention on this site is to say so rather than fill the gap.
What would break it: Growth normalising back toward the mid-single-digit five-year sales CAGR once the base effect washes out.
Q1 FY27 (reported July 2026): revenue ₹1,815 Cr, +39% YoY; PAT ₹173 Cr, +44%.
The case
Order book ₹13,596 Cr at 30 June 2026 across 11 projects and 44 marine platforms — roughly 1.8× trailing revenue, on a balance sheet with almost no debt and a 43% return on capital. The chain behind it is budgeted: India's FY2026-27 defence modernisation allocation is ₹1,85,467 Cr, up 24.6%, with 75% ring-fenced for domestic industry, and the shipyards' combined order pipeline was reported at ₹2.35 lakh crore running to 2035.
The bear case
Margin and timing both slipped in the same quarter. Q1 EBITDA margin fell 30bps year on year to 8.2% on higher material costs, and the Next Generation Corvette order — over ₹33,000 Cr — has slipped on slower-than-expected finalisation, deferring revenue recognition. Antique cut its target to ₹2,990 from ₹3,141 on 30 July 2026. One customer, a handful of programmes.
What would break it: The NGC award slipping past FY28, or the order book falling below ~₹12,000 Cr.
Q1 FY27 (reported July 2026): revenue ₹819.7 Cr, +172% YoY; PAT ₹85.3 Cr, +180%; operating EBITDA margin 14.7%.
The case
Confirmed order book ₹2,506.9 Cr at 30 June 2026, plus ₹848 Cr at L1 and a stated pipeline of ₹10,410 Cr — several times trailing revenue. It sits at the ODM and design stage of the electronics chain rather than in contract assembly, which is why it earns a 14.7% EBITDA margin where assemblers earn 3–4%. The demand anchor is dated and public: the IndiaAI Mission carries a sanctioned outlay of ₹10,372 Cr and had more than 38,000 GPUs onboarded to its common compute facility by 25 March 2026.
The bear case
Customer concentration moved the wrong way as revenue tripled. The top 10 customers were 87.71% of Q1 FY27 revenue, up from 76.42% in FY26. A revenue line growing this fast while concentrating is one contract renewal away from a step down, and the order book gives no protection against that.
What would break it: Top-10 concentration staying above 85% while order-book growth stalls.
1,312 stores at 30 June 2026 — Westside 301, Zudio 982, 29 lifestyle hubs — across 330 cities and more than 18 million sq ft, with 23 net additions in the quarter. Long-term targets are 5,000 Zudio stores at 200–250 a year and 700 Westside at about 50 a year. CareEdge sized India's apparel retail market at ₹9.30 lakh crore in FY25 heading to US$193bn by FY30 (19 January 2026), with organised retail growing 10–13%.
The bear case
Growth is decelerating and the market has already repriced it. Q1 FY27 standalone revenue growth of 19% came 150–200bps below consensus against 20% a year earlier, revenue per square foot is estimated down 5–7% year on year, and same-store growth is in low single digits. The stock fell 12.65% on 7 July 2026 on the business update alone.
What would break it: Same-store sales growth going negative while store additions continue — expansion masking a per-store problem.
Q1 FY27 (reported 5 August 2026): revenue ₹702 Cr, +88.1% YoY; PAT ₹413 Cr, +103.3%; EBITDA margin 70.4%.
The case
Average daily turnover reached ₹10.49 lakh crore in Q1 FY27, up 238% year on year, with options notional ADT of ₹9,89,691 Cr, up 266%. Across FY2025-26 commodity futures turnover rose 133% to ₹166.4 trillion and options premium turnover more than doubled to ₹16.8 trillion. SEBI's commodity reform package of 12 August 2026 — margin rationalisation, agri position-limit guidelines and wider FPI access to physically settled non-agri derivatives — widens the addressable base further.
The bear case
The peak may already be behind it, and the regulator is the business risk. Q1 FY27 revenue fell 21% sequentially from ₹889 Cr, PAT fell 22% from ₹530 Cr, and EBITDA margin compressed about 450bps from 74.9% to 70.4%. The entire earnings base is derivatives volume, which a regulator can reprice with one circular — tighter RBI norms in July 2026 sent MCX and BSE down four consecutive sessions.
What would break it: A second consecutive quarter of sequential decline, or any position-limit tightening on non-agri options.
Q1 FY27 (reported early August 2026): revenue ₹231 Cr, +22.8% YoY; PAT ₹53.1 Cr, +37.6%; EBITDA ₹98 Cr at a 42.7% margin.
The case
166 centres across 27 cities at the end of Q1 FY27, with 9 hub centres and 10–12 spokes to be commissioned over the following 12 months — funded by ₹190–195 Cr of FY27 capex entirely from internal accruals, so the expansion does not need the balance sheet. Guidance is high double-digit FY27 growth with 40–45% EBITDA margins sustained. India's diagnostic labs market was valued at US$10.95bn in 2025 and is projected at US$28.53bn by 2034, an 11.23% CAGR.
The bear case
It is a regional business being read as a national one. Hyderabad still contributes 67% of revenue, the last price increase was taken in June 2025 and applied only to Hyderabad, and the Bengaluru and Pune ramp-ups run at a sub-1.5% margin drag. Pricing headroom in the core market is limited and the new markets are not yet paying for themselves.
What would break it: Hyderabad's revenue share failing to fall below ~60% by FY28, meaning the expansion is not converting.
Q1 FY27 (reported 6 August 2026): revenue ₹893.6 Cr, +20.7% YoY; PAT ₹193.7 Cr, +27.8%; EBITDA ₹294.9 Cr at a 33% margin.
The case
Management targets ₹3,000 Cr of EBITDA by FY30 against ₹1,000 Cr as at December 2025. The TruBridge acquisition closed 9 July 2026, adding roughly US$347m of revenue and US$69m of adjusted EBITDA and consolidating from Q2 FY27, with an identified US$575m cross-sell whitespace inside TruBridge's client base. The US revenue cycle management market was US$172.24bn in 2024 heading to US$308.2bn by 2030, a 10.1% CAGR.
The bear case
The growth is now bought, and levered. IKS raised roughly US$600m of five-year debt to fund the US$557m TruBridge purchase, taking leverage to about 3× EBITDA — ICICI Securities flagged the near-term financial risk. The debt-to-equity of 0.34 shown in the table predates that deal closing, so the screen is reading a balance sheet that no longer exists.
What would break it: Leverage still near 3× EBITDA at FY28 with the cross-sell whitespace unconverted.
Net cash of ₹3,990 Cr against Q1 capex of ₹320 Cr, and a government EPC order book of ₹10,900 Cr — BharatNet ₹8,000 Cr, of which ₹4,500 Cr is in execution, plus RDSS ₹3,250 Cr. Under the National Electricity Plan the transmission network grows from about 5.09 lakh circuit km in June 2026 to 6.48 lakh ckm by 2032 and transformation capacity from 1,478 to 2,345 GVA, on a roughly ₹9 trillion programme. Project Spring targets 11–13% Wires & Cables EBIT margins and exports above 10% of topline by 2030.
The bear case
The supply response is already dated and already biting. UltraTech launches cables and wires before December 2026 and Adani's Kutch Copper is building out, with analysts estimating a near-20% industry capacity increase by end-FY27 against roughly 10% volume growth. Polycab already took a 3–4% price correction in early July 2026 after copper fell from ₹14,000 to ₹13,100–13,200 and aluminium dropped 18–20%. International Wires & Cables revenue fell 13% in the quarter.
What would break it: Wires & Cables EBIT margin below 11% for two consecutive quarters once UltraTech's distribution ramps.
Q1 FY27 (reported 13 August 2026): consolidated revenue ₹332 Cr, +33% YoY; PAT ₹148 Cr, +42%; EBITDA margin 64%. Excluding roughly 5% of revenue from one-time items, underlying revenue was +20% and EBITDA +25% at a 61% margin.
The case
FY27 guidance is specific: about 700,000 TEU of containers (4–5% growth), 260,000–270,000 RoRo cars, 2.4–2.6m MT of dry bulk and 1.3–1.4m MT of liquid, on roughly ₹200 Cr of capex — chiefly a liquid jetty due for completion in March 2027 that lifts liquid capacity from 2 to 5m MT. India's port expansion pipeline, set out by the Ministry of Ports, Shipping and Waterways on 31 July 2026, targets 682 MTPA of additional capacity by 2030.
The bear case
Two dated problems, one of them existential. Management assumes the Middle East-linked Shaheen service stays suspended for all of FY27, a loss of 70,000–80,000 TEU a year, and Q1 liquid cargo already fell 47% year on year on a 63% drop in LPG volumes. Separately, the Gujarat Maritime Board concession expires in September 2028 with an extension still under negotiation — a terminal business whose right to operate is unrenewed three years out.
What would break it: The GMB concession extension not settled by FY28, or container volumes missing the 700,000 TEU guide.
Q1 FY27 (reported 8 August 2026): revenue ₹638.0 Cr, +6.0% YoY; PAT ₹109.1 Cr, down 23.9% from ₹143.3 Cr.
The case
Kavach 4.0 was commissioned on 2,633 route km as at July 2026, with 21,794 km at various stages of installation and roughly 9,000 further km planned over the next two years, on top of the 7,200 locomotives already fitted. HBL is one of a very small number of approved suppliers, and the returns the screen picked up are real — 58.5% return on capital on effectively no debt.
The bear case
This entry contradicts itself, and the page shows it rather than burying it. The screen ranks HBL first on trailing figures while its most recent quarter went backwards: profit fell 23.9% on revenue up 6.0%, as total expenses rose 19.0% and defence and aviation batteries revenue fell 48.5% to ₹37.9 Cr. The order book is shrinking too — ₹2,999 Cr at 31 December 2025 against ₹4,479 Cr at 31 July 2025 (CARE Ratings, 25 February 2026), and no 30 June 2026 figure has been disclosed.
What would break it: Already breaking. A second consecutive quarter of falling profit would confirm the trailing screen is measuring a peak that has passed.
Q1 FY27 (reported 10 August 2026): revenue ₹936.5 Cr, +81% YoY; PAT ₹352.6 Cr, +163%; EBITDA ₹507.5 Cr at a 54% margin against 41% a year earlier.
The case
Ore production was 3.67m tonnes in FY2025-26, targeted at about 4.7m tonnes in FY2026-27 and 12.2 MTPA by FY2029-30, backed by roughly ₹7,200 Cr of capex over 2026–2030 funded from internal accruals rather than debt. India crossed 300 GW of non-fossil power capacity in August 2026, past 60% of its 500 GW-by-2030 target, and the grid and renewables build-out behind that is copper-intensive.
The bear case
Vision 2030 asks for more than a tripling of ore output in four years across three simultaneous underground expansions — Malanjkhand 2.5→5.0, Khetri 1.5→3.0 and ICC 0.4→4.2 MTPA — while the Gujarat Copper Project remains non-operational with revenue-sharing production targeted only by Q4 FY27. And the 54% margin is a copper price outcome, not an operating achievement: this is a commodity producer whose earnings invert when the price does.
What would break it: FY27 ore output missing about 4.7m tonnes, which would make the 12.2 MTPA path arithmetically unreachable.
Q1 FY27 (reported 28 July 2026): consolidated revenue ₹278.9 Cr, +39.8% YoY; PAT ₹85.4 Cr, +45%; EBITDA ₹131.8 Cr at a 43.6% margin against 44.6%.
The case
Running order book of ₹3,047 Cr at 30 June 2026 — over three times trailing revenue — with about ₹800 Cr guided for FY27 execution and more than 60% expected to convert within two to two-and-a-half years. The 15-year, ₹1,402 Cr ONGC production enhancement contract for the Rajahmundry Asset starts delivering incremental production from October 2026, with management targeting over ₹150 Cr from that contract alone in FY28. It sits at the services layer of a chain where this site's own Oil & Gas map shows the asset owners earning 10–14%.
The bear case
A ₹4,218 Cr company on ₹970 Cr of revenue, concentrated on a single dominant customer. An uncontrolled gas flow at ONGC's Mori #5 well during workover operations, disclosed 6 January 2026, already pushed the production enhancement contract's incremental-production start out to October 2026. When one customer sets both the order book and the timetable, execution risk is not diversifiable.
What would break it: The Rajahmundry contract slipping past October 2026 again, or FY27 execution missing the ~₹800 Cr guide.
Q1 FY27 (reported early August 2026): revenue ₹231 Cr, +22.8% YoY; PAT ₹53.1 Cr, +37.6%; EBITDA ₹98 Cr at a 42.7% margin.
The case
166 centres across 27 cities at the end of Q1 FY27, with 9 hub centres and 10–12 spokes to be commissioned over the following 12 months — funded by ₹190–195 Cr of FY27 capex entirely from internal accruals, so the expansion does not need the balance sheet. Guidance is high double-digit FY27 growth with 40–45% EBITDA margins sustained. India's diagnostic labs market was valued at US$10.95bn in 2025 and is projected at US$28.53bn by 2034, an 11.23% CAGR.
The bear case
It is a regional business being read as a national one. Hyderabad still contributes 67% of revenue, the last price increase was taken in June 2025 and applied only to Hyderabad, and the Bengaluru and Pune ramp-ups run at a sub-1.5% margin drag. Pricing headroom in the core market is limited and the new markets are not yet paying for themselves.
What would break it: Hyderabad's revenue share failing to fall below ~60% by FY28, meaning the expansion is not converting.
Q1 FY27 (reported 16 July 2026): revenue ₹1,555.5 Cr, +51% YoY; PAT ₹380.3 Cr, +103%, at a 24.2% PAT margin against 18.0%. Module production 970 MW, +53%.
The case
Order book of 9.9 GW at 30 June 2026, and capacity moving from 10.3 GW of modules and 2.94 GW of TOPCon cells to 16.3 GW and 8.9 GW by early FY28 on a roughly ₹5,500 Cr expansion — the new module line operational by December 2026, the cell line by March 2027. The scarcity it is building into is dated and specific: ALMM List-II's domestic cell mandate took effect in June 2026 against ALMM-enrolled module capacity of about 194 GW versus roughly 30 GW of cell capacity (16–18 GW effective) by May 2026, with a projected ~21 GW cell supply gap in 2027.
The bear case
Read the listing date before the growth rate. Emmvee listed on 18 November 2025, so the five-year CAGR on this page is pre-IPO restated history rather than a listed track record; revenue at listing was ₹2,360.3 Cr for FY2025. Repeat customers account for 57% of that 9.9 GW order book. And Wood Mackenzie forecasts utility-scale solar system prices rising 20% by Q4 2026 on cell shortages — a cost that module buyers eventually resist, which is how a shortage premium ends.
What would break it: The cell line missing March 2027, which would leave it a module assembler in a segment where enrolled capacity is 194 GW against roughly 50 GW of annual demand.
Q2 CY2026 (reported 28 July 2026): revenue ₹8,451.2 Cr, +20.4% YoY; PAT ₹1,525.4 Cr, +15.1%. Volumes 466.7m cases, +19.8% — India +14.4%, international +38.4%.
The case
53 production facilities, 38 in India and 15 international, with the growth engine now clearly offshore at +38.4% volume growth. That is built on the ₹1,131.4 Cr Twizza acquisition in South Africa and a US$32m (₹305 Cr) Devyani Food Industries investment in Kenya, with ₹490 Cr of capital work-in-progress at 30 June 2026 directed at South African expansion and a Kenya CSD line.
The bear case
Profit is growing slower than revenue and the market repriced it the same day. EBITDA margin contracted 76bps year on year to 27.7% from 28.5% on consolidation of the lower-margin Twizza business, and the stock fell about 8% after the 28 July 2026 results. Buying international volume at a lower margin is a permanent mix decision, not a one-quarter effect.
What would break it: EBITDA margin below 27% while India volume growth slows under 10%.
Q1 FY27 (reported 8 August 2026): revenue ₹638.0 Cr, +6.0% YoY; PAT ₹109.1 Cr, down 23.9% from ₹143.3 Cr.
The case
Kavach 4.0 was commissioned on 2,633 route km as at July 2026, with 21,794 km at various stages of installation and roughly 9,000 further km planned over the next two years, on top of the 7,200 locomotives already fitted. HBL is one of a very small number of approved suppliers, and the returns the screen picked up are real — 58.5% return on capital on effectively no debt.
The bear case
This entry contradicts itself, and the page shows it rather than burying it. The screen ranks HBL first on trailing figures while its most recent quarter went backwards: profit fell 23.9% on revenue up 6.0%, as total expenses rose 19.0% and defence and aviation batteries revenue fell 48.5% to ₹37.9 Cr. The order book is shrinking too — ₹2,999 Cr at 31 December 2025 against ₹4,479 Cr at 31 July 2025 (CARE Ratings, 25 February 2026), and no 30 June 2026 figure has been disclosed.
What would break it: Already breaking. A second consecutive quarter of falling profit would confirm the trailing screen is measuring a peak that has passed.
Q1 FY27 (reported July 2026): consolidated total income ₹610.7 Cr, +15.2% YoY; PAT ₹260.9 Cr, +19.0%.
The case
AUM ₹13,648 Cr at 30 June 2026, up 21%, on disbursements of ₹1,053 Cr, up 36%. Management retained FY27 guidance of 22–24% AUM growth, flagged July 2026 disbursements up 25% year on year, and guided Q2 FY27 disbursement growth of 25–30%. PMAY-Urban 2.0, launched 1 September 2024, targets 1 crore urban houses over five years with ₹2.50 lakh crore of central assistance against roughly ₹10 lakh crore of total investment.
The bear case
Credit quality is deteriorating on a trend, not a blip: gross NPAs went 1.19% at FY25-end, to 1.52% at 31 March 2026, to 1.70% at 30 June 2026, which management attributed to collection difficulty in the NBFC portfolio. The stock fell 5.77% on the result. Affordable-housing borrowers are the first cohort to feel a slowdown and the last to recover.
What would break it: Gross NPA past 2% while AUM growth holds at 22–24% — growing into a deteriorating book.
Stage 6 · Downstream / Distribution / End Markets · NSE: NESTLEIND
ROCE
84.1%
Sustained growth
11.1%
Profit growth
10.6%
Op. margin
23.5%
Debt / equity
0.08
Market cap
₹269,578 Cr
Q1 FY27 (reported 22 July 2026): revenue from operations ₹6,378.2 Cr, +25.2% YoY; standalone PAT ₹975.1 Cr, +47.9% (consolidated ₹958.7 Cr, +48.3%); EBITDA ₹1,538.1 Cr at a 24.1% margin.
The case
All four product groups grew double digits in the June 2026 quarter, exports grew 35.6% year on year, and the company reported a 20th consecutive quarter of double-digit beverages growth. Capex guidance is above ₹2,000 Cr a year, including a tenth Indian factory at Khordha, Odisha — a ₹900 Cr first phase whose foundation was laid on 4 April 2025. It leads both the Dairy and Sugar chains on this screen, at an 84.1% return on capital.
The bear case
The 48% profit jump is measured against a depressed base: Q1 FY26 profit had itself fallen 12% to ₹659 Cr. Management flagged cocoa and sugar as inflationary on erratic rainfall and lower crop estimates, plus demand-driven inflation in dairy proteins. UNVERIFIABLE: no credible dated multi-year forecast for India's packaged-foods market could be sourced for this entry, so it carries no market-size claim — the convention on this site is to say so rather than fill the gap.
What would break it: Growth normalising back toward the mid-single-digit five-year sales CAGR once the base effect washes out.
Screen output only — no argued note has been verified for this company yet. Read the figures above and the chain map; nothing here has been checked against its latest results.
1,312 stores at 30 June 2026 — Westside 301, Zudio 982, 29 lifestyle hubs — across 330 cities and more than 18 million sq ft, with 23 net additions in the quarter. Long-term targets are 5,000 Zudio stores at 200–250 a year and 700 Westside at about 50 a year. CareEdge sized India's apparel retail market at ₹9.30 lakh crore in FY25 heading to US$193bn by FY30 (19 January 2026), with organised retail growing 10–13%.
The bear case
Growth is decelerating and the market has already repriced it. Q1 FY27 standalone revenue growth of 19% came 150–200bps below consensus against 20% a year earlier, revenue per square foot is estimated down 5–7% year on year, and same-store growth is in low single digits. The stock fell 12.65% on 7 July 2026 on the business update alone.
What would break it: Same-store sales growth going negative while store additions continue — expansion masking a per-store problem.
Q1 FY27 (reported August 2026): revenue ₹890.5 Cr, +25.3% YoY; PAT ₹201.6 Cr, +11.4%; EBITDA ₹252.4 Cr at a 28.3% margin.
The case
46 client governments across more than 100 countries on five- to ten-year contracts, with management guiding to 15–20% organic revenue growth over the next five years. The UIDAI District-Level Aadhaar Seva Kendra mandate won on 26 August 2025 is worth about ₹2,055 Cr over six years, with ₹125 Cr invested up front and revenue recognition expected between Q4 FY27 and Q1 FY28. Indians filed 1.15m Schengen visa applications in 2025 — third globally, out of nearly 12m worldwide (European Commission, 29 May 2026).
The bear case
The volume has stopped growing. Core visa applications were flat in Q1 FY27 at 11.3 lakh, and the 21.6% visa-segment revenue growth came from realisation — net revenue per application up 11.2% to ₹3,521 — rather than volume, against geopolitical disruption in Eastern European markets. Price-led growth has a ceiling that volume-led growth does not, and profit already grew at less than half the rate of revenue.
What would break it: Application volumes still flat in FY28 with realisation growth below 5%.
Not covered by /best-positioned, so there is nothing to compare against.
Ratios as at 8 Sep 2026, from the same Screener export as every map on this site. The written note on each chain leader was checked against sources dated to August 2026 and carries its own links; where a claim could not be sourced it is marked UNVERIFIABLE rather than filled in. Across the chains both pages cover, this screen agrees with /best-positioned on 35 names and differs on 27. Disagreement is expected: one page is a rule applied mechanically, the other is an argument. Not investment advice.